FOLFIRINOX vs gemcitabine nab-paclitaxel: A real-world efficacy and safety analysis - a single-centre experience

被引：0
作者：
Khan, A. M. [1 ]
Noor, S. [2 ]
Ahmed, R. [3 ]
Takreem, S. [2 ]
Shahnoor, S. S. [2 ]
Muddu, V. K. [2 ,4 ]
Bonda, A. [5 ]
Siripurapu, I. [5 ]
Krishnaiah, S. [6 ]
Rao, G. [7 ]
Reddy, N. [8 ]
机构：
[1] Asian Inst Gastroenterol, Dept Med Oncol, Hyderabad, India
[2] Anwarul Uloom Coll Pharm, Pharm Practice, Hyderabad, India
[3] Anwarul Uloom Coll Pharm, Pharm, Hyderabad, India
[4] AIG Hosp Hyderabad, Med Oncol, Hyderabad, India
[5] AIG Hosp, Dept Med Oncol, Hyderabad, India
[6] Asian Inst Gastroenterol, Biostat, Hyderabad, India
[7] Asian Inst Gastroenterol, Surg Gastroenterol, Hyderabad, India
[8] Asian Inst Gastroenterol, Med Gastroenterol, Hyderabad, India
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.517
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
376P
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 50 条
[41]   Lipid lowering with inclisiran: a real-world single-centre experience [J].
Padam, Pritpal ;
Barton, Lucy ;
Wilson, Stewart ;
David, Alessia ;
Walji, Shahenaz ;
de Lorenzo, Ferruccio ;
Ray, Kausik K. ;
Jones, Ben ;
Cegla, Jaimini .
OPEN HEART, 2022, 9 (02)
[42]   Sacubitril-Valsartan: real-world single-centre experience [J].
Climent, Herminio Morillas ;
Lopez, Alvaro Vicedo ;
Moya, Julia Seller ;
Torres, Edgard Alania ;
Jornet, Emilio Galcera ;
Rodriguez, Ainhoa Larumbe ;
Piles, Carlos Nunez ;
Munoz, Alfonso Valle .
EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 :257-257
[43]   Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre Experience [J].
Ghorani, Ehsan ;
Wong, Han Hsi ;
Hewitt, Carole ;
Calder, Joanna ;
Corrie, Pippa ;
Basu, Bristi .
ONCOLOGY, 2015, 89 (05) :281-287
[44]   Adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for resected pancreatic ductal adenocarcinoma: A single center experience in China [J].
Zhu-Zeng Yin ;
Zhi-Ming Zhao ;
Wen-Bo Tang ;
Nan Jiang ;
Ke-Di Zhang ;
Yu-Yao Song ;
Yang Wang ;
Cheng-Gang Li ;
Yuan-Xing Gao ;
Rong Liu .
World Journal of Clinical Cases, 2020, (13) :2778-2786
[45]   Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world data [J].
Boyne, Devon J. ;
Brenner, Darren R. ;
Gupta, Alind ;
Mackay, Eric ;
Arora, Paul ;
Wasiak, Radek ;
Cheung, Winson Y. ;
Hernan, Miguel A. .
ANNALS OF EPIDEMIOLOGY, 2023, 78 :28-34
[46]   Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review (vol 11, pg 1, 2019) [J].
Chiorean, Elena Gabriela ;
Cheung, Winson Y. ;
Giordano, Guido ;
Kim, George ;
Al-Batran, Salah-Eddin .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
[47]   Adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for resected pancreatic ductal adenocarcinoma: A single center experience in China [J].
Yin, Zhu-Zeng ;
Zhao, Zhi-Ming ;
Tang, Wen-Bo ;
Jiang, Nan ;
Zhang, Ke-Di ;
Song, Yu-Yao ;
Wang, Yang ;
Li, Cheng-Gang ;
Gao, Yuan-Xing ;
Liu, Rong .
WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (13) :2778-2786
[48]   Clinical outcomes of FOLFIRINOX and gemcitabine–nab paclitaxel for metastatic pancreatic cancer in the real world setting [J].
F. Franco ;
J. C. Camara ;
J. I. Martín-Valadés ;
A. López-Alfonso ;
D. Marrupe ;
D. Gutiérrez-Abad ;
B. Martínez-Amores ;
A. León ;
I. Juez ;
M. Pérez ;
A. Royuela ;
A. Ruiz-Casado .
Clinical and Translational Oncology, 2021, 23 :812-819
[49]   Efficacy and safety of neoadjuvant Folfirinox and Gemcitabine plus Nab-Paclitaxel for borderline resectable and locally advanced pancreatic cancer: a systematic review and meta-analysis [J].
Dong, L. -p. ;
Liu, Y. -m. ;
Lu, W. -j. ;
Tang, K. -z. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (17) :6316-6327
[50]   Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer [J].
Hakon Blomstrand ;
Ursula Scheibling ;
Charlotte Bratthäll ;
Henrik Green ;
Nils O. Elander .
BMC Cancer, 19
12345